IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 225 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $68,432 | -40.8% | 11,200 | -38.1% | 0.00% | 0.0% |
| Q4 2022 | $115,659 | -53.9% | 18,100 | -30.9% | 0.00% | -66.7% |
| Q3 2022 | $250,996 | +0.4% | 26,200 | +231.6% | 0.00% | +50.0% |
| Q1 2021 | $250,000 | -43.8% | 7,900 | -17.7% | 0.00% | -60.0% |
| Q4 2020 | $445,000 | +46.9% | 9,600 | +4.3% | 0.01% | +66.7% |
| Q3 2020 | $303,000 | -40.9% | 9,200 | -50.8% | 0.00% | -50.0% |
| Q2 2020 | $513,000 | -16.9% | 18,700 | -9.2% | 0.01% | -25.0% |
| Q1 2020 | $617,000 | +9.8% | 20,600 | +1.5% | 0.01% | +33.3% |
| Q4 2019 | $562,000 | – | 20,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
| Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
| Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
| Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
| Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
| QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
| Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |